Uloric 40 mg Oral Tablet
RxNorm 834239
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 834239 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Uloric 40 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Febuxostat 40 mg Oral Tablet [Uloric]
(Atom ID: 2945701)
PSNPrescribable
Prescribable Name (PSN):
Uloric 40 mg Oral Tablet
(Atom ID: 6364711)
SYPrescribable
Synonym (SY):
Uloric 40 mg Oral Tablet
(Atom ID: 2945702)
Patient Education
Febuxostat
Febuxostat is used to treat gout in adults who were not treated successfully with or who are not able to take allopurinol (Aloprim, Zyloprim). Gout is a type of arthritis in which uric acid, a naturally occurring substance in the body, builds up in the joints and causes sudden attacks of redness, swelling, pain, and heat in one or more joints. Febuxostat is in a class of medications called xanthine oxidase inhibitors. It works by decreasing the amount of uric acid that is made in the body. Febuxostat is used to prevent gout attacks but not to treat them once they occur.
[Learn More]
* Please review the disclaimer below.